Co-Authors
This is a "connection" page, showing publications co-authored by Alessandra Oliva and Gabriella d'Ettorre.
Connection Strength
0.844
-
Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19. Front Immunol. 2021; 12:708149.
Score: 0.239
-
Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects. Microorganisms. 2019 Jun 03; 7(6).
Score: 0.206
-
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
Score: 0.060
-
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
Score: 0.059
-
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization. Infez Med. 2020 Dec 01; 28(4):534-538.
Score: 0.057
-
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
Score: 0.057
-
Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
Score: 0.056
-
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
Score: 0.055
-
Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
Score: 0.055